PRO-155

N/A

Report date: 2023/11/16 10:59:29
NME

Base Information

Drug NamePRO-155
Drug Alias NameZebesten oftenoPRO-155
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsCataract
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMexico
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLaboratorios Sophia Sa De Cv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCataract

Other Information

ATC CodeN/A
Related LinksN/A